BTX-1801
/ Botanix Pharma
- LARVOL DELTA
Home
Next
Prev
1 to 2
Of
2
Go to page
1
March 28, 2022
Antimicrobial profile of BTX-1801: a new synthetic cannabinoid active against Gram-positive bacteria associated with serious infections
(ECCMID 2022)
- No abstract available
Infectious Disease
March 28, 2022
Bactericidal activity of BTX1801: a synthetic cannabinoid with potent activity versus Staphylococcus aureus
(ECCMID 2022)
- No abstract available
1 to 2
Of
2
Go to page
1